Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

HAL SKOPICKI

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1346264553
CMS profile
333750
Location
ISLANDIA, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$308.21

5 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $308.21 5

By paying entity

PY2025 · entire year · sorted by reported total

Paying entityAmountRecords
Abbott Laboratories $270.44 3
Novartis Pharmaceuticals Corporation $37.77 2

Page 1 of 1; records 1–5 of 5 matching records. This page contains 5 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

HAL SKOPICKI

NPI 1346264553 · CMS profile ID 333750

Allopathic & Osteopathic Physicians / Internal Medicine / Cardiovascular Disease

ISLANDIA, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–5 of 5 matching records. This page contains 5 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1346264553?year=2025&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
HAL SKOPICKI, NPI 1346264553, CMS profile ID 333750. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–5 of 5 matching records. This page contains 5 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1346264553?year=2025&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). HAL SKOPICKI, NPI 1346264553, CMS profile ID 333750. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–5 of 5 matching records. This page contains 5 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1346264553?year=2025&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
HAL SKOPICKI, NPI 1346264553, CMS profile ID 333750, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–5 of 5 matching records. This page contains 5 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1346264553?year=2025&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

5 matching records · $308.21 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 5 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–5 of 5.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Novartis Pharmaceuticals Corporation $19.4612/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200463186 CMS
Abbott Laboratories $142.7512/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1240871462 CMS
Abbott Laboratories $12.5012/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1240871466 CMS
Abbott Laboratories $115.1910/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1240672735 CMS
Novartis Pharmaceuticals Corporation $18.3107/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200388240 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $14,139.99 16
PY2020 $647.26 8
PY2021 $12,069.00 12
PY2022 $2,586.05 5
PY2023 $295.23 4
PY2024 $443.71 6
PY2025 $308.21 5

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $123,059.53 14
PY2024 Principal investigator $131,886.60 14
PY2023 Principal investigator $177,782.25 13
PY2022 Principal investigator $122,194.96 15
PY2021 Principal investigator $219,308.12 45
PY2020 Principal investigator $152,408.74 95
PY2019 Principal investigator $126,188.89 103

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

13 records in PY2023

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 AstraZeneca Pharmaceuticals LP $2,329.17 12/31/2023 Non-covered Recipient Entity
RESEARCH FOUND OF SUNY
This is a randomised double blind placebo controlled multi center sequential phase 2b and Phase 3 study to evaluate the efficacy and safety of AZD4831 administered for up to 48 Weeks in participants with heart failure with left ventricular ejection fractio No dispute reported 06/30/2026 991137281
Principal investigator 1 ENDOTRONIX, INC. $86,699.23 12/31/2023 Non-covered Recipient Entity
STONYBROOK UNIVERSITY MEDICAL CENTER
PROACTIVE-HF No dispute reported 06/30/2026 1054738649
Principal investigator 1 Medtronic, Inc. $16,994.00 11/14/2023 Non-covered Recipient Entity
Research Foundation State University New York
ALLEVIATE-HF No dispute reported 06/30/2026 993703443
Principal investigator 1 Medtronic, Inc. $4,800.00 11/14/2023 Non-covered Recipient Entity
Research Foundation State University New York
ALLEVIATE-HF No dispute reported 06/30/2026 993703445
Principal investigator 1 American Regent $2,100.00 06/14/2023 Non-covered Recipient Entity
The Research Foundation For The Stateuniversity Of New York
Heart_FID No dispute reported 06/30/2026 989343091
Principal investigator 1 Eli Lilly and Company $20,929.00 05/09/2023 Non-covered Recipient Entity
RESEARCH FOUNDATION OF STATE UNIV OF NY
A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED PHASE 3 STUDY COMPARING THE EFFICACY AND SAFETY OF TIRZEPATIDE VERSUS PLACEBO IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION AND OBESITY (SUMMIT No dispute reported 06/30/2026 1038136153
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $3,770.00 03/28/2023 Non-covered Recipient Entity
The Research Foundation For The State Univ Of Ny
BAY94-8862 LCM HFmr/pEF (EF 40%) No dispute reported 06/30/2026 1000202843
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $1,240.00 02/21/2023 Non-covered Recipient Entity
The Research Foundation For The State Univ Of Ny
BAY94-8862 LCM HFmr/pEF (EF 40%) No dispute reported 06/30/2026 1000202829
Principal investigator 1 AstraZeneca Pharmaceuticals LP $22,550.00 02/17/2023 Non-covered Recipient Entity
RESEARCH FOUND OF SUNY
This is a randomised double blind placebo controlled multi center sequential phase 2b and Phase 3 study to evaluate the efficacy and safety of AZD4831 administered for up to 48 Weeks in participants with heart failure with left ventricular ejection fractio No dispute reported 06/30/2026 991129487
Principal investigator 1 Eli Lilly and Company $2.94 02/14/2023 Covered Recipient Teaching Hospital
HELEN HAYES HOSPITAL
A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED PHASE 3 STUDY COMPARING THE EFFICACY AND SAFETY OF TIRZEPATIDE VERSUS PLACEBO IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION AND OBESITY (SUMMIT No dispute reported 06/30/2026 1038060961
Principal investigator 1 Novartis Pharmaceuticals Corporation $11,796.00 02/01/2023 Non-covered Recipient Entity
STONY BROOK UNIVERSITY MEDICAL CENTER CSPP100F2301
Prospective comparison of ARNI with ARB Given following stabiLization In DEcompensated HFpEF (PARAGLIDE-HFpEF) No dispute reported 06/30/2026 1017208713
Principal investigator 1 American Regent $3,851.00 01/19/2023 Non-covered Recipient Entity
The Research Foundation For The Stateuniversity Of New York
Heart_FID No dispute reported 06/30/2026 989343089
Principal investigator 1 Eli Lilly and Company $720.91 01/11/2023 Non-covered Recipient Entity
STONY BROOK UNIVERSITY HOSPITAL
A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED PHASE 3 STUDY COMPARING THE EFFICACY AND SAFETY OF TIRZEPATIDE VERSUS PLACEBO IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION AND OBESITY (SUMMIT No dispute reported 06/30/2026 1038154257